Molecular Mechanisms of Obesity-Induced Osteoporosis and Muscle Atrophy
Open accessThe DOI matches its Crossref record; 28 of the 28 references it cites were found in a registry or an index.
Abstract
Obesity and osteoporosis are two alarming health disorders prominent among middle and old age populations, and the numbers of those affected by these two disorders are increasing. It is estimated that more than 600 million adults are obese and over 200 million people have osteoporosis worldwide. Interestingly, both of these abnormalities share some common features including a genetic predisposition, and a common origin: bone marrow mesenchymal stromal cells. Obesity is characterized by the expression of leptin, adiponectin, interleukin 6 (IL-6), interleukin 10 (IL-10), monocyte chemotactic protein-1 (MCP-1), tumor necrosis factor-alpha (TNF-α), macrophage colony stimulating factor (M-CSF), growth hormone (GH), parathyroid hormone (PTH), angiotensin II (Ang II), 5-hydroxy-tryptamine (5-HT), Advance glycation end products (AGE), and myostatin, which exert their effects by modulating the signaling pathways within bone and muscle. Chemical messengers (e.g., TNF-α, IL-6, AGE, leptins) that are upregulated or downregulated as a result of obesity have been shown to act as negative regulators of osteoblasts, osteocytes and muscles, as well as positive regulators of osteoclasts. These additive effects of obesity ultimately increase the risk for osteoporosis and muscle atrophy. The aim of this review is to identify the potential cellular mechanisms through which obesity may facilitate osteoporosis, muscle atrophy and bone fractures.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
WNT signaling in bone homeostasis and disease: From human mutations to treatments
Baron, R., & Kneissel, M. (2013) · Nature Medicine · doi:10.1038/nm.3074 · Cited by 2,093
TGF-β and BMP Signaling in Osteoblast Differentiation and Bone Formation
Chen, G., Deng, C., & Li, Y.-P. (2012) · International Journal of Biological Sciences · doi:10.7150/ijbs.2929 · Cited by 1,756 · cited 2×
“Osteocytes are thought to remodel their perilacunar space, coordinate the response to mechanical loading and unloading and perform nutrient/waste exchange through blood (Lampropoulos et al., 2012; Dallas et al., 2013).”
Mechanisms regulating skeletal muscle growth and atrophy
Schiaffino, S., Dyar, K. A., Ciciliot, S., Blaauw, B., & Sandri, M. (2013) · The FEBS Journal · doi:10.1111/febs.12253 · Cited by 1,492
Cellular and molecular mechanisms of muscle atrophy
Bonaldo, P., & Sandri, M. (2013) · Disease Models & Mechanisms · doi:10.1242/dmm.010389 · Cited by 1,284
Muscle wasting in disease: molecular mechanisms and promising therapies
Cohen, S., Nathan, J. A., & Goldberg, A. L. (2015) · Nature Reviews Drug Discovery · doi:10.1038/nrd4467 · Cited by 1,089
Makki, K., Froguel, P., & Wolowczuk, I. (2013) · ISRN Inflammation · doi:10.1155/2013/139239 · Cited by 1,085 · cited 5×
“…of proinflammatory cytokines and chemokines like TNF-α, IL1, IL-6, and MCP-1, and these factors have adverse effects on the differentiation and activation of osteoblasts while having supportive effects on osteoclasts (Weisberg et al., 2003; Cao, 2011; Redlich and Smolen, 2012; Makki et al., 2013).”
BackgroundInfluentialThe Osteocyte: An Endocrine Cell … and More
Dallas, S. L., Prideaux, M., & Bonewald, L. F. (2013) · Endocrine Reviews · doi:10.1210/er.2012-1026 · Cited by 1,042
Adiponectin and AdipoR1 Regulate PGC-1α and Mitochondria by Ca2+ and AMPK/SIRT1
Iwabu, M., Yamauchi, T., Okada-Iwabu, M., Sato, K., Nakagawa, T., Funata, M., Yamaguchi, M., Namiki, S., Nakayama, R., Tabata, M., et al. (2010) · Nature · doi:10.1038/nature08991 · Cited by 971
Regulation of skeletal muscle growth by the IGF1-Akt/PKB pathway: insights from genetic models
Schiaffino, S., & Mammucari, C. (2011) · Skeletal Muscle · doi:10.1186/2044-5040-1-4 · Cited by 816 · cited 2×
“This finding suggests the role of obesity as a positive modulator of IL-6R and IL-6 expression in adipose tissue (Sindhu et al., 2015).”
BackgroundGlucocorticoid-Induced Skeletal Muscle Atrophy
Schakman, O., Kalista, S., Barbé, C., Loumaye, A., & Thissen, J. P. (2013) · The International Journal of Biochemistry & Cell Biology · doi:10.1016/j.biocel.2013.05.036 · Cited by 705 · cited 1×
“…types of mediators such as NF-κB, RANKL, osteopontin (OPN), TNF-α, IL-6, M-CSF, and monocyte chemoattractant protein 1 (MCP1) have prominent Frontiers in Physiology | www.frontiersin.org 6 September 2016 | Volume 7 | Article 439 roles to induce this process (Redlich and Smolen, 2012; Roy, 2013).”
BackgroundThe roles of vitamin D in skeletal muscle: form, function, and metabolism
Girgis, C. M., Clifton-Bligh, R. J., Hamrick, M. W., Holick, M. F., & Gunton, J. E. (2013) · Endocrine Reviews · doi:10.1210/er.2012-1012 · Cited by 567
Signaling pathways controlling skeletal muscle mass
Egerman, M. A., & Glass, D. J. (2014) · Critical Reviews in Biochemistry and Molecular Biology · doi:10.3109/10409238.2013.857291 · Cited by 555
Differential Effects of Interleukin-6 and -10 on Skeletal Muscle and Liver Insulin Action In Vivo
Kim, H.-J., Higashimori, T., Park, S.-Y., Choi, H., Dong, J., Kim, Y.-J., Noh, H.-L., Cho, Y.-R., Cline, G., Kim, Y.-B., et al. (2004) · Diabetes · doi:10.2337/diabetes.53.4.1060 · Cited by 534
Myostatin and the skeletal muscle atrophy and hypertrophy signaling pathways
Rodriguez, J., Vernus, B., Chelh, I., Cassar-Malek, I., Gabillard, J. C., Hadj Sassi, A., Seiliez, I., Picard, B., & Bonnieu, A. (2014) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-014-1689-x · Cited by 397 · cited 2×
“Deactivation of the IGF-1-PI3K-AKT signaling pathway and upregulation of FOXO1 signaling is achieved by myostatin treatment (Rodriguez et al., 2014).”
BackgroundSkeletal Muscle Triglycerides, Diacylglycerols, and Ceramides in Insulin Resistance
Amati, F., Dubé, J. J., Alvarez-Carnero, E., Edreira, M. M., Chomentowski, P., Coen, P. M., Switzer, G. E., Bickel, P. E., Stefanovic-Racic, M., Toledo, F. G. S., et al. (2011) · Diabetes · doi:10.2337/db10-1221 · Cited by 395
Physical Inactivity and Obesity: A Vicious Circle
Pietiläinen, K. H., Kaprio, J., Borg, P., Plasqui, G., Yki‐Järvinen, H., Kujala, U. M., Rose, R. J., Westerterp, K. R., & Rissanen, A. (2008) · Obesity · doi:10.1038/oby.2007.72 · Cited by 388 · cited 3×
“GCs have also been reported to inhibit osteoblastogenesis by inhibiting RUNX2, an important osteogenic transcription factor (Rauch et al., 2010).”
BackgroundThe Influence of Estrogen on Skeletal Muscle: Sex Matters
Enns, D. L., & Tiidus, P. M. (2010) · Sports Medicine · doi:10.2165/11319760-000000000-00000 · Cited by 374
Wang, C., Jackson, G., Jones, T. H., Matsumoto, A. M., Nehra, A., Perelman, M. A., Swerdloff, R. S., Traish, A., Zitzmann, M., & Cunningham, G. (2011) · Diabetes Care · doi:10.2337/dc10-2339 · Cited by 366
Increased secretion and expression of myostatin in skeletal muscle from extremely obese women
Hittel, D. S., Berggren, J. R., Shearer, J., Boyle, K., & Houmard, J. A. (2009) · Diabetes · doi:10.2337/db08-0943 · Cited by 324 · cited 2×
“From this data, it can be concluded that elevated levels of myostatin are associated with obesity (Hittel et al., 2009), and that this contributes to decreased muscle mass.”
BackgroundEffect of obesity on falls, injury, and disability
Himes, C. L., & Reynolds, S. L. (2012) · Journal of the American Geriatrics Society · doi:10.1111/j.1532-5415.2011.03767.x · Cited by 296 · cited 1×
“IL-6 Is Increased in Obesity and Antagonizes”
The effects of obesity on skeletal muscle regeneration
Akhmedov, D., & Berdeaux, R. (2013) · Frontiers in Physiology · doi:10.3389/fphys.2013.00371 · Cited by 241 · cited 6×
“Lipotoxicity caused by accumulated acyl CoAs, diacylglycerols and ceramides adversely affect muscle development and regeneration (Akhmedov and Berdeaux, 2013).”
BackgroundInfluentialRadical roles for RAGE in the pathogenesis of oxidative stress in cardiovascular diseases and beyond
Daffu, G., Del Pozo, C., O'Shea, K., Ananthakrishnan, R., Ramasamy, R., & Schmidt, A. (2013) · International Journal of Molecular Sciences · doi:10.3390/ijms141019891 · Cited by 222
Differential role of insulin/IGF-1 receptor signaling in muscle growth and glucose homeostasis
O’Neill, B. T., Lauritzen, H. P. M. M., Hirshman, M. F., Smyth, G., Goodyear, L. J., & Kahn, C. R. (2015) · Cell Reports · doi:10.1016/j.celrep.2015.04.037 · Cited by 171
Sishi, B., Loos, B., Ellis, B., Smith, W., du Toit, E. F., & Engelbrecht, A.-M. (2011) · Experimental Physiology · doi:10.1113/expphysiol.2010.054189 · Cited by 162 · cited 2×
“Expression of both MuRF1 and atrogin-1 have been shown to be elevated in obese mice muscle compared to nonobese mice (Wang et al., 2010; Sishi et al., 2011).”
BackgroundArmamento-Villareal, R., Sadler, C., Napoli, N., Shah, K., Chode, S., Sinacore, D. R., Qualls, C., & Villareal, D. T. (2012) · Journal of Bone and Mineral Research · doi:10.1002/jbmr.1560 · Cited by 158 · cited 8×
“SOST and DKK1, through their inhibition of Wnt signaling, lead to increased activation of transcription factors that act as negative regulators of osteogenesis, leading to decreased bone formation.”
BackgroundInfluentialSáinz, N., Rodríguez, A., Catalán, V., Becerril, S., Ramírez, B., Gómez-Ambrosi, J., & Frühbeck, G. (2009) · PLoS ONE · doi:10.1371/journal.pone.0006808 · Cited by 135 · cited 3×
“…is a 167-amino acid peptide and is the product of the ob gene that is secreted by white adipose tissue (WAT) and also by a variety of other tissues including placenta, mammary gland, ovary, skeletal muscle, stomach, pituitary gland, and lymphoid tissue (Sainz et al., 2009; Park and Ahima, 2015).”
BackgroundGenetic Link Between Obesity and MMP14-Dependent Adipogenic Collagen Turnover
Chun, T.-H., Inoue, M., Morisaki, H., Yamanaka, I., Miyamoto, Y., Okamura, T., Sato-Kusubata, K., & Weiss, S. J. (2010) · Diabetes · doi:10.2337/db10-0073 · Cited by 97 · cited 1×
“An in situ study by Chun et al. concluded that high-fat diets acutely trigger the MMP14-dependent degradation of type I collagen fibers (Chun et al., 2010).”
BackgroundRegulation of Insulin and Leptin Signaling by Muscle Suppressor of Cytokine Signaling 3 (SOCS3)
Yang, Z., Hulver, M., McMillan, R. P., Cai, L., Kershaw, E. E., Yu, L., Xue, B., & Shi, H. (2012) · PLoS ONE · doi:10.1371/journal.pone.0047493 · Cited by 90 · cited 2×
“Both leptin and insulin resistance in myocytes are associated with the onset of obesity, type 2 diabetes, and other metabolic disorders (Yang et al., 2012).”
Background
Cited by
Liao, C.-D., Tsauo, J.-Y., Wu, Y.-T., Cheng, C.-P., Chen, H.-C., Huang, Y.-C., Chen, H.-C., & Liou, T.-H. (2017) · The American Journal of Clinical Nutrition · doi:10.3945/ajcn.116.143594 · Cited by 317
Collins, K. H., Herzog, W., MacDonald, G. Z., Reimer, R. A., Rios, J. L., Smith, I. C., Zernicke, R. F., & Hart, D. A. (2018) · Frontiers in Physiology · doi:10.3389/fphys.2018.00112 · Cited by 308
Obesity and Bone: A Complex Relationship
Rinonapoli, G., Pace, V., Ruggiero, C., Ceccarini, P., Bisaccia, M., Meccariello, L., & Caraffa, A. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms222413662 · Cited by 261
Strategies to Prevent Sarcopenia in the Aging Process: Role of Protein Intake and Exercise
Rogeri, P. S., Zanella, R., Martins, G. L., Garcia, M. D. A., Leite, G., Lugaresi, R., Gasparini, S. O., Sperandio, G. A., Ferreira, L. H. B., Souza-Junior, T. P., et al. (2021) · Nutrients · doi:10.3390/nu14010052 · Cited by 181
Buscemi, S., Buscemi, C., Corleo, D., De Pergola, G., Caldarella, R., Meli, F., Randazzo, C., Milazzo, S., Barile, A. M., Rosafio, G., et al. (2021) · Nutrients · doi:10.3390/nu13061829 · Cited by 32
Metadata
- Authors
- Roy, B., Curtis, M. E., Fears, L. S., Nahashon, S. N., & Fentress, H. M.
- Venue
- Frontiers in Physiology
- Publisher
- Frontiers Media SA
- Published
- 2016-09-29
- Volume
- 7
- Pages
- 439-439
- ISSN
- 1664-042X (ISSN-L)
- OpenAlex
- W2525553990
- Cited by
- 116
- References
- 28
- FWCI
- 4.66
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.